CCA
AZN icon

Checchi Capital Advisers’s AstraZeneca AZN Stock Holding History

Checchi Capital Advisers’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.82M Buy
9,648
+6
+0.1% +$1.13K 0.08% 144
2026
Q1 		$1.9M Sell
9,642
-220
-2% -$42.4K 0.1% 137
2025
Q4 		$1.81M Sell
9,862
-370
-4% -$64.9K 0.09% 137
2025
Q3 		$1.57M Buy
10,232
+310
+3% +$46.9K 0.08% 145
2025
Q2 		$1.39M Sell
9,922
-666
-6% -$93.3K 0.08% 170
2025
Q1 		$1.56M Buy
10,588
+546
+5% +$79K 0.08% 154
2024
Q4 		$1.32M Sell
10,042
-178
-2% -$24.9K 0.08% 159
2024
Q3 		$1.59M Sell
10,220
-12
-0.1% -$1.94K 0.09% 140
2024
Q2 		$1.6M Buy
10,232
+85
+0.8% +$12.8K 0.08% 135
2024
Q1 		$1.37M Sell
10,147
-406
-4% -$53.8K 0.11% 152
2023
Q4 		$1.42M Sell
10,553
-1,510
-13% -$196K 0.12% 147
2023
Q3 		$1.63M Sell
12,063
-138
-1% -$18.8K 0.15% 118
2023
Q2 		$1.75M Buy
12,201
+762
+7% +$112K 0.16% 112
2023
Q1 		$1.59M Buy
11,439
+308
+3% +$41.4K 0.15% 119
2022
Q4 		$1.51M Buy
11,131
+55
+0.5% +$6.9K 0.16% 118
2022
Q3 		$1.22M Buy
11,076
+49
+0.4% +$6.22K 0.11% 135
2022
Q2 		$1.46M Buy
11,027
+2,211
+25% +$290K 0.13% 125
2022
Q1 		$1.17M Buy
8,816
+327
+4% +$39.2K 0.1% 145
2021
Q4 		$989K Buy
8,489
+449
+6% +$52.8K 0.09% 154
2021
Q3 		$966K Buy
8,040
+418
+5% +$48.7K 0.1% 144
2021
Q2 		$913K Sell
7,622
-61
-0.8% -$6.69K 0.09% 159
2021
Q1 		$764K Buy
7,683
+217
+3% +$21.8K 0.08% 174
2020
Q4 		$746K Buy
7,466
+41
+0.6% +$4.34K 0.08% 176
2020
Q3 		$814K Sell
7,425
-315
-4% -$35K 0.09% 137
2020
Q2 		$819K Sell
7,740
-72
-0.9% -$7.44K 0.1% 137
2020
Q1 		$698K Buy
7,812
+349
+5% +$32.9K 0.07% 132
2019
Q4 		$744K Sell
7,463
-1,122
-13% -$106K 0.1% 140
2019
Q3 		$765K Sell
8,585
-260
-3% -$22.5K 0.1% 130
2019
Q2 		$730K Sell
8,845
-185
-2% -$14.5K 0.09% 139
2019
Q1 		$730K Buy
9,030
+1,004
+13% +$79.1K 0.09% 131
2018
Q4 		$610K Buy
8,026
+49
+0.6% +$3.83K 0.08% 145
2018
Q3 		$631K Sell
7,977
-1,467
-16% -$111K 0.07% 170
2018
Q2 		$663K Buy
9,444
+1,649
+21% +$119K 0.08% 152
2018
Q1 		$545K Sell
7,795
-216
-3% -$15K 0.07% 173
2017
Q4 		$556K Sell
8,011
-689
-8% -$46.5K 0.07% 177
2017
Q3 		$589K Sell
8,700
-1,806
-17% -$114K 0.06% 150
2017
Q2 		$716K Buy
10,506
+420
+4% +$27.4K 0.08% 126
2017
Q1 		$628K Buy
10,086
+1,450
+17% +$84.4K 0.07% 139
2016
Q4 		$472K Sell
8,636
-1,951
-18% -$111K 0.06% 180
2016
Q3 		$696K Sell
10,587
-349
-3% -$22.8K 0.08% 123
2016
Q2 		$660K Buy
10,936
+332
+3% +$19.3K 0.08% 121
2016
Q1 		$597K Buy
10,604
+146
+1% +$8.77K 0.13% 127
2015
Q4 		$710K Buy
10,458
+171
+2% +$11.2K 0.18% 105
2015
Q3 		$655K Buy
10,287
+896
+10% +$58.9K 0.18% 104
2015
Q2 		$598K Buy
9,391
+1,114
+13% +$76.3K 0.16% 118
2015
Q1 		$566K Buy
8,277
+1,090
+15% +$75.7K 0.17% 122
2014
Q4 		$506K Buy
7,187
+220
+3% +$15.8K 0.19% 118
2014
Q3 		$498K Sell
6,967
-432
-6% -$31.6K 0.2% 103
2014
Q2 		$550K Buy
7,399
+2,254
+44% +$163K 0.25% 80
2014
Q1 		$334K Buy
5,145
+36
+0.7% +$2.33K 0.2% 100
2013
Q4 		$303K Buy
+5,109
New +$278K 0.24% 88

Other funds holding AZN

EPGL
Evelyn Partners Group Ltd London $46.9B AUM
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $20.1B AUM 16.62% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Checchi Capital Advisers's AZN Position: Q2 2026 in Review

Checchi Capital Advisers increased its AstraZeneca (AZN) stake by 0.06% in Q2 2026, buying an estimated $1.13K and bringing the position to 9,648 shares worth $1.82M. The position accounts for 0.08% of the portfolio, ranked #144.

Checchi Capital Advisers first reported a position in AZN in Q4 2013 and has held it in 51 quarters since. The position peaked at $1.9M in Q1 2026. 906 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Checchi Capital Advisers held 9,648 shares of AstraZeneca worth $1.82M as of Q2 2026.
  • Checchi Capital Advisers bought 6 AstraZeneca shares in Q2 2026, an estimated $1.13K.
  • AstraZeneca made up 0.08% of Checchi Capital Advisers's portfolio in Q2 2026, its #144 holding.
  • Checchi Capital Advisers first reported a position in AstraZeneca in Q4 2013 and has held it in 51 quarters since.
  • Checchi Capital Advisers's AstraZeneca position peaked at $1.9M in Q1 2026.
  • 906 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Checchi Capital Advisers's 13F filing for Q2 2026, filed 4 Aug 2026.